Listed by the USPTO as MACFARLANE, STACEY NEE
Tech Center 1600 • Art Units: 1645 1649 1675 1678
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18474419 | Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitor | Non-Final OA | Boehringer Ingelheim International GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy53.7% of resolved applications examined by Stacey Nee Macfarlane were allowed (842 resolved cases), compared with 49.5% across Art Unit 1645 over the last five years.
This examiner's interview lift is +39.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Stacey Nee Macfarlane took 1,223 days on average from filing to allowance.
Stacey Nee Macfarlane examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
